# Aspirin Responsiveness and Outcome in Coronary Artery Bypass Graft (CABG) Surgery

> **NCT01174862** · — · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 304 (actual)

## Conditions studied

- Coronary Artery Bypass Graft Triple Vessel
- Myocardial Ischemia
- Thrombosis
- Antithrombotic Drugs [Platelet-aggregation Inhibitors] Causing Adverse Effects in Therapeutic Use

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01174862
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2012-06
- **Final completion:** 2013-06
- **Target enrollment:** 304 (ACTUAL)
- **Last updated:** 2015-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01174862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01174862, "Aspirin Responsiveness and Outcome in Coronary Artery Bypass Graft (CABG) Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01174862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*